EBCC: Beta-Blocker Role in Breast Cancer Examined (CME/CE, with audio)

posted on Mar 30 by in the Uncategorized category BARCELONA (MedPage Today) -- Breast cancer patients on concomitant beta-blocker therapy had significantly better outcomes compared with other patients, including a reduced risk of metastasis and improved disease-specific survival, data from a retrospective study showed.

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes